Potent neutralizing monoclonal antibodies against Ebola virus infection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Qi ^a   Gui, Miao ^a   Niu, Xuefeng ^b   He, Shihua ^c,d   Wang, Ruoke ^a   Feng, Yupeng ^e   Kroeker, Andrea ^c,d   Zuo, Yanan ^a   Wang, Hua ^a   Wang, Ying ^a   Li, Jiade ^a   Li, Chufang ^b   Shi, Yi ^f   Shi, Xuanling ^a   Gao, George F ^f   Xiang, Ye ^a   Qiu, Xiangguo ^c,d   Chen, Ling ^b,e   Zhang, Linqi ^a  

^a Tsinghua University   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^f INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL; B LYMPHOCYTE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE; PASSIVE IMMUNIZATION; RHESUS MONKEY; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EBOLAVIRUS; EPITOPES; HEMORRHAGIC FEVER, EBOLA; IMMUNIZATION, PASSIVE; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MICE; VACCINATION;

EID: 84975256732     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25856     Document Type: Article

References (64)

1. Baize, S., et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371, 1418-1425 (2014
2. Feldmann, H., & Geisbert, T. W. Ebola haemorrhagic fever. Lancet 377, 849-862 (2010
3. Barrette, R. W., et al. Discovery of swine as a host for the Reston ebolavirus. Science 325, 204-206 (2009
4. Leroy, E. M., et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303, 387-390 (2004
5. Walsh, P. D., et al. Catastrophic ape decline in western equatorial Africa. Nature 422, 611-614 (2003
6. Kuhn, J. H., et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-Adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol 158, 1425-1432 (2013
7. Carroll, M. W., et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature 524, 97-101 (2015
8. Gire, S. K., et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369-1372 (2014
9. Hoenen, T., et al. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science 348, 117-119 (2015
10. Park, D. J., et al. Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone. Cell 161, 1516-1526 (2015
11. Simon-Loriere, E., et al. Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic. Nature 524, 102-104 (2015
12. Tong, Y. G., et al. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature 524, 93-96 (2015
13. Misasi, J., & Sullivan, N. J. Camouflage and misdirection: the full-on assault of ebola virus disease. Cell 159, 477-486 (2014
14. Lee, J. E., et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182 (2008
15. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643-1645 (2005
16. Baize, S., et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virusinfected patients. Nat Med 5, 423-426 (1999
17. Leroy, E. M., et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210-2215 (2000
18. Henao-Restrepo, A. M., et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386, 857-866 (2015
19. Zhu, F. C., et al. Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet 385, 2272-2279 (2015
20. Dye, J. M., et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci USA 109, 5034-5039 (2012
21. Marzi, A., et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLos One 7, e36192 (2012
22. Olinger, G. G., Jr., et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA 109, 18030-18035 (2012
23. Qiu, X., et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4, 138ra181 (2012
24. Qiu, X., et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53 (2014
25. Pettitt, J., et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med 5, 199ra113 (2013
26. Oswald, W. B., et al. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLos Pathog 3, e9 (2007
27. Parren, P. W., Geisbert, T. W., Maruyama, T., Jahrling, P. B., & Burton, D. R. Pre- And postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 76, 6408-6412 (2002
28. Lyon, G. M., et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371, 2402-2409 (2014
29. Murin, C. D., et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad Sci USA 111, 17182-17187 (2014
30. Takada, A., et al. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol 77, 1069-1074 (2003
31. Wilson, J. A., et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287, 1664-1666 (2000
32. Davidson, E., et al. Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. J Virol 89, 10982-10992 (2015
33. Holtsberg, F. W., et al. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. J Virol 90, 266-278 (2015
34. Keck, Z. Y., et al. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. J Virol 90, 279-291 (2015
35. Reynard, O., & Volchkov, V. E. Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP. J Infect Dis 212 Suppl 2, S372-378 (2015
36. Lee, J. E., & Saphire, E. O. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Curr Opin Struct Biol 19, 408-417 (2009
37. Furuyama, W., et al. Discovery of an antibody for pan-ebolavirus therapy. Sci Rep 6, 20514 (2016
38. Bornholdt, Z. A., et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351, 1078-1083 (2016
39. Corti, D., et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351, 1339-1342 (2016
40. Flyak, A. I., et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell 164, 392-405 (2016
41. Misasi, J., et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 351, 1343-1346 (2016
42. Zeitlin, L., et al. Antibody therapeutics for Ebola virus disease. Curr Opin Virol 17, 45-49 (2016
43. Cook, J. D., & Lee, J. E. The secret life of viral entry glycoproteins: moonlighting in immune evasion. PLos Pathog 9, e1003258 (2013
44. Francica, J. R., et al. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLos Pathog 6, e1001098 (2010
45. Ehrenmann, F., Kaas, Q., & Lefranc, M. P. IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and Mhc SF. Nucleic Acids Res 38, D301-307 (2009
46. Shedlock, D. J., et al. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 401, 228-235 (2010
47. Webb, N. E., Montefiori, D. C., & Lee, B. Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies. Nat Commun 6, 8443 (2015
48. Wu, X., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593-1602 (2011
49. Maruyama, T., et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73, 6024-6030 (1999
50. Audet, J., et al. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci Rep 4, 6881 (2014
51. Maganga, G. D., et al. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 371, 2083-2091 (2014
52. Schieffelin, J. S., et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 371, 2092-2100 (2014
53. Hood, C. L., et al. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol 84, 2972-2982 (2010
54. Wang, H., et al. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1. Cell 164, 258-268 (2016
55. Ponomarenko, J., Vaughan, K., Sette, A., & Maurer-Stroh, S. Conservancy of mAb Epitopes in Ebolavirus Glycoproteins of Previous and 2014 Outbreaks. PLos Curr 6 (2015
56. Kugelman, J. R., et al. Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. Cell Rep 12, 2111-2120 (2015
57. de La Vega, M. A., Stein, D., & Kobinger, G. P. Ebolavirus Evolution: Past and Present. PLos Pathog 11, e1005221 (2015
58. Shi, Y., et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342, 243-247 (2013
59. Tiller, T., et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329, 112-124 (2008
60. Jiang, L., et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6, 234ra259 (2014
61. Tang, G., et al. EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157, 38-46 (2007
62. Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180, 519-530 (2012
63. Wriggers, W. Using Situs for the integration of multi-resolution structures. Biophys Rev 2, 21-27 (2010
64. Pettersen, E. F., et al. UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612 (2004